The value of carcinoembryonic antigen in differentiating sclerosing epithelial hamartoma from syringoma.
We examined 4 cases of sclerosing epithelial hamartoma for the presence of carcinoembryonic antigen (CEA) by the unlabelled antibody peroxidase-antiperoxidase method but could not detect CEA in these lesions. Because syringomas contain CEA, the detection of this antigen is a useful marker for differentiating sclerosing epithelial hamartomas from syringomas.
D000236:Adenoma / Q000032:analysis / Q000175:diagnosis* / Q000473:pathology; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D003937:Diagnosis, Differential; D006222:Hamartoma / Q000032:analysis / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D007124:Immunoenzyme Techniques; D012598:Sclerosis; D012878:Skin Neoplasms / Q000032:analysis / Q000175:diagnosis* / Q000473:pathology; D013544:Sweat Gland Neoplasms / Q000032:analysis / Q000175:diagnosis* / Q000473:pathology
D002272:Carcinoembryonic Antigen